Abstract
Hairy cell leukemia (HCL) is predominantly seen in men with a median age of 52, and often treated with 2-chlorodeoxyadenosine (cladribine, 2-CdA). Perhaps as a result of the demographics of HCL, studies of ovarian function after such therapy are lacking, even though cladribine can induce DNA strand breaks. In this report, the first case of a patient diagnosed with HCL who then went on to a successful pregnancy is described, suggesting that fertility may be preserved in at least some female patients treated with this agent.
Original language | English (US) |
---|---|
Pages (from-to) | 187-188 |
Number of pages | 2 |
Journal | Leukemia and Lymphoma |
Volume | 45 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2004 |
Externally published | Yes |
Keywords
- Cladribine
- Hairy cell leukaemia
- Pregnancy
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research